Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tiziana Life Sciences PLC

1.57
+0.09006.08%
Post-market: 1.620.0500+3.18%18:46 EDT
Volume:377.22K
Turnover:589.16K
Market Cap:163.28M
PE:-11.77
High:1.60
Open:1.56
Low:1.50
Close:1.48
Loading ...

Tiziana Life Sciences Regains Compliance With Nasdaq Listing Rule

MT Newswires Live
·
14 Mar

Tiziana Life Sciences Regains Compliance With Nasdaq Listing Minimum Bid Price Rule

THOMSON REUTERS
·
14 Mar

Oramed Pharmaceuticals And 2 Other Penny Stocks With Promising Potential

Simply Wall St.
·
14 Mar

Tiziana Life Sciences Files New Drug Application for ALS Drug Candidate

MT Newswires Live
·
04 Mar

BRIEF-Tiziana Life Sciences Files Investigational New Drug Application With FDA For ALS Phase 2 Clinical Trial

Reuters
·
04 Mar

Tiziana Life Sciences files IND application with FDA for ALS Phase 2 trial

TIPRANKS
·
04 Mar

Tiziana Life Sciences Files Investigational New Drug Application With FDA for ALS Phase 2 Clinical Trial

THOMSON REUTERS
·
04 Mar

Why Tiziana Life Sciences Ltd (TLSA) is Skyrocketing So Far in 2025

Insider Monkey
·
02 Mar

Tiziana Life Sciences Announces Groundbreaking Study Published in Nature Neuroscience Demonstrating Positive Results for Nasal Anti-CD3 Therapy in Traumatic Brain Injury

GlobeNewswire
·
27 Feb

Tiziana : Nasal Anti-Cd3 (Foralumab) Preclinical Study Nearing Completion, Foralumab Could Offer Treatment for Long Covid

THOMSON REUTERS
·
25 Feb

Tiziana Life Sciences Announces Long Covid Study to Complete in Second Quarter

GlobeNewswire
·
25 Feb

‘Time to Pull the Plug,’ Says Top Investor About Tesla Stock

TIPRANKS
·
24 Feb

BRIEF-Tiziana Life Sciences Announces Agreement With Renaissance Lakewood

Reuters
·
21 Feb

BRIEF-Tiziana Life Sciences Announces Agreement For Product Development Services With Renaissance Lakewood, Llc

Reuters
·
21 Feb

Tiziana Life Sciences Teams Up With Renaissance Lakewood on Nasal Drug Delivery

MT Newswires Live
·
21 Feb

Tiziana enters product development services agreement with Renaissance

TIPRANKS
·
21 Feb